OTCMKTS:ACUR
Acura Pharmaceuticals Stock News
$0.0028
+0 (+0%)
At Close: Apr 17, 2024
Acura, Abuse Deterrent Pharmaceuticals amend license deal for pain drug LIMITx LTX-03
11:55am, Tuesday, 01'st Mar 2022 Seeking Alpha
Acura Pharmaceuticals (ACUR) amended a license, development and commercialization agreement for its product candidate LIMITx LTX-03 with Abuse Deterrent Pharmaceuticals to extend the…
Acura Pharmaceuticals (OTCMKTS:ACUR) Shares Pass Above 200 Day Moving Average of $0.55
07:38am, Saturday, 11'th Dec 2021 Dakota Financial News
Shares of Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.55 and traded as high as $0.55. Acura Pharmaceuticals shares last traded at $0.55, with a volume of 2,404 shares traded. The company has a quick ratio of 0.86, a []
Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results
09:15pm, Monday, 15'th Nov 2021 Intrado Digital Media
PALATINE, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technologies and products intended to address safe use of medications, announced today financial results for the three and nine months ended September 30, 2021.
Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results
04:15pm, Monday, 16'th Aug 2021
PALATINE, Ill., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCQB: ACUR), an innovative drug delivery company engaged in the research, development and commercialization of technolog
